Active	Status	Sponsor type	Region	Phase	Filter
4 Active 2 Inactive 6 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes: « July » « 2025 » M T W T F S S 30 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 1 2 3   - « July » « 2025 » M T W T F S S 30 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 1 2 3   Show only changed items Enrollment:

Advanced Filters

4 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Sauvageau, Eric
ESCAPE-NEXT, NCT04462536 / 2020-002360-30: Efficacy and Safety of Nerinetide in Participants With Acute Ischemic Stroke Undergoing Endovascular Thrombectomy Excluding Thrombolysis	Completed	3	850	Europe, Canada, US, RoW	Placebo, Nerinetide, NA-1	NoNO Inc., University of Calgary	Stroke, Acute	08/23	08/23
ESCAPE-MeVO, NCT05151172: EndovaSCular TreAtment to imProve outcomEs for Medium Vessel Occlusions ( Trial)	Active, not recruiting	N/A	530	Europe, Canada, US	endovascular thrombectomy (EVT), solitaire X, Standarad medical care	Dr. Michael D Hill, University of Calgary	Acute Ischemic Stroke	12/25	06/26
ARTISSE, NCT02998229: The Artisse™ Intrasaccular Device is Indicated for the Treatment of Wide-neck Bifurcating Intracranial Aneurysms (IAs).	Recruiting	N/A	220	US	Artisse™ Intrasaccular Device	Medtronic Neurovascular Clinical Affairs	Intracranial Aneurysm	02/28	02/32
Ebreo, Nancy
VOTER, NCT03999983: Vertebral Artery Origin Treatment Via Endovascular Techniques Registry	Recruiting	N/A	150	US	Observational Prospective Registry, Observational	St. Louis University	Vertebral Artery Stenosis	03/26	12/26

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Sauvageau, Eric
ESCAPE-NEXT, NCT04462536 / 2020-002360-30: Efficacy and Safety of Nerinetide in Participants With Acute Ischemic Stroke Undergoing Endovascular Thrombectomy Excluding Thrombolysis	Completed	3	850	Europe, Canada, US, RoW	Placebo, Nerinetide, NA-1	NoNO Inc., University of Calgary	Stroke, Acute	08/23	08/23
ESCAPE-MeVO, NCT05151172: EndovaSCular TreAtment to imProve outcomEs for Medium Vessel Occlusions ( Trial)	Active, not recruiting	N/A	530	Europe, Canada, US	endovascular thrombectomy (EVT), solitaire X, Standarad medical care	Dr. Michael D Hill, University of Calgary	Acute Ischemic Stroke	12/25	06/26
ARTISSE, NCT02998229: The Artisse™ Intrasaccular Device is Indicated for the Treatment of Wide-neck Bifurcating Intracranial Aneurysms (IAs).	Recruiting	N/A	220	US	Artisse™ Intrasaccular Device	Medtronic Neurovascular Clinical Affairs	Intracranial Aneurysm	02/28	02/32
Ebreo, Nancy
VOTER, NCT03999983: Vertebral Artery Origin Treatment Via Endovascular Techniques Registry	Recruiting	N/A	150	US	Observational Prospective Registry, Observational	St. Louis University	Vertebral Artery Stenosis	03/26	12/26